Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
SARS-CoV-2 Spike S1 Chimeric Recombinant Human Monoclonal Antibody (hIgA2001), GenScript™
Human Recombinant Monoclonal Antibody
Supplier: Genscript Corporation A02071100
Description
SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. It caused coronavirus disease 2019 (COVID-19). SARS-CoV-2 contains glycosylated spike (S) protein, which is composed of S1 subunit and S2 subunit. The S1 contains a receptor-binding domain (RBD) that can bind to ACE2 receptor on target cells.SARS-CoV-2 Spike S1 Antibody (hIgA2001), Human Chimeric is produced from cell culture in vitro under conditions free from animal-derived components.
SARS-CoV-2 Spike S1 Chimeric Recombinant Monoclonal antibody specifically detects SARS-CoV-2 Spike S1 Chimeric in Virus samples. It is validated for ELISASpecifications
| SARS-CoV-2 Spike S1 Chimeric | |
| Recombinant Monoclonal | |
| 1 mg/mL | |
| PBS with 0.02% sodium azide; pH 7.4 | |
| Human | |
| Affinity chromatography | |
| RUO | |
| Virus | |
| Antibody | |
| IgA |
| ELISA | |
| hIgA2001 | |
| Unconjugated | |
| Coronavirus; COVID; Covid 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Spike Protein; SARS-CoV2; SARS-CoV-2 | |
| Recombinant SARS-CoV-2 RBD Protein | |
| 100 μg | |
| Primary | |
| -20°C | |
| Liquid |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction